Secondary Logo

Journal Logo

October 2017 - Volume 37 - Issue 5
pp: 493-640

Use of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density Change: A Population-Based Longitudinal Study in Middle-Aged and Elderly Individuals

Ham, Annelies C.; Aarts, Nikkie; Noordam, Raymond; More

Journal of Clinical Psychopharmacology. 37(5):524-530, October 2017.

No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial

Hofmeijer-Sevink, Mieke Klein; Duits, Puck; Rijkeboer, Marleen M.; More

Journal of Clinical Psychopharmacology. 37(5):531-539, October 2017.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor– or Serotonin-Norepinephrine Reuptake Inhibitor–Resistant Depression in Adult Women

Kious, Brent M.; Sabic, Hana; Sung, Young-Hoon; More

Journal of Clinical Psychopharmacology. 37(5):578-583, October 2017.